NCT05208047
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05208047
Title (Peak) a Phase 3 Randomized Trial of CGT9486+Sunitinib Vs. Sunitinib in Subjects with Gastrointestinal Stromal Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Cogent Biosciences, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | POL | NOR | NLD | ITA | HUN | GBR | FRA | ESP | DNK | DEU | CZE | CAN | BRA | AUS | ARG


No variant requirements are available.